Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Abbott Labs (ABT) PT Raised to $140 at Cowen
January 27, 2021 4:24 PM ESTCowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $140.00 (from $113.00) while maintaining a Outperform rating.
The analyst comments "ABT finished 2020 with 28% organic sales growth and guided to 2021 EPS growth of more than 35%, which still looks conservative. We have... More
Abbott (ABT) Tops Q1 EPS by 10c, Offers FY Guidance
January 27, 2021 7:35 AM ESTAbbott (NYSE: ABT) reported Q1 EPS of $1.45, $0.10 better than the analyst estimate of $1.35. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $9.94 billion.
GUIDANCE:
Abbott sees 2021 EPS of at least $5.00, versus the consensus of $4.37.
Abbott... More